Kiora Pharmaceuticals Stock Market Value
| KPRX Stock | USD 3.31 0.11 3.22% |
| Symbol | Kiora |
Kiora Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kiora Pharmaceuticals. If investors know Kiora will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kiora Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 16.53 | Revenue Per Share 7.424 | Return On Assets 0.1296 | Return On Equity 0.1369 |
The market value of Kiora Pharmaceuticals is measured differently than its book value, which is the value of Kiora that is recorded on the company's balance sheet. Investors also form their own opinion of Kiora Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Kiora Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kiora Pharmaceuticals' market value can be influenced by many factors that don't directly affect Kiora Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kiora Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Kiora Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kiora Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Kiora Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Kiora Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Kiora Pharmaceuticals.
| 12/02/2022 |
| 11/21/2024 |
If you would invest 0.00 in Kiora Pharmaceuticals on December 2, 2022 and sell it all today you would earn a total of 0.00 from holding Kiora Pharmaceuticals or generate 0.0% return on investment in Kiora Pharmaceuticals over 720 days. Kiora Pharmaceuticals is related to or competes with ZyVersa Therapeutics, Sonnet Biotherapeutics, Zura Bio, Phio Pharmaceuticals, Transcode Therapeutics, and Quoin Pharmaceuticals. Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies fo... More
Kiora Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Kiora Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Kiora Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 16.59 | |||
| Value At Risk | (4.97) | |||
| Potential Upside | 5.95 |
Kiora Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Kiora Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Kiora Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Kiora Pharmaceuticals historical prices to predict the future Kiora Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.29) | |||
| Total Risk Alpha | (0.64) | |||
| Treynor Ratio | (0.26) |
Kiora Pharmaceuticals Backtested Returns
Kiora Pharmaceuticals has Sharpe Ratio of -0.039, which conveys that the firm had a -0.039% return per unit of risk over the last 3 months. Kiora Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Kiora Pharmaceuticals' Mean Deviation of 2.77, standard deviation of 3.73, and Risk Adjusted Performance of (0.03) to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.83, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Kiora Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Kiora Pharmaceuticals is expected to be smaller as well. At this point, Kiora Pharmaceuticals has a negative expected return of -0.14%. Please make sure to verify Kiora Pharmaceuticals' total risk alpha, kurtosis, as well as the relationship between the Kurtosis and price action indicator , to decide if Kiora Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.84 |
Very good predictability
Kiora Pharmaceuticals has very good predictability. Overlapping area represents the amount of predictability between Kiora Pharmaceuticals time series from 2nd of December 2022 to 27th of November 2023 and 27th of November 2023 to 21st of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Kiora Pharmaceuticals price movement. The serial correlation of 0.84 indicates that around 84.0% of current Kiora Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.84 | |
| Spearman Rank Test | 0.79 | |
| Residual Average | 0.0 | |
| Price Variance | 0.75 |
Kiora Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Kiora Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Kiora Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Kiora Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Kiora Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Kiora Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Kiora Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Kiora Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Kiora Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Kiora Pharmaceuticals Lagged Returns
When evaluating Kiora Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Kiora Pharmaceuticals stock have on its future price. Kiora Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Kiora Pharmaceuticals autocorrelation shows the relationship between Kiora Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Kiora Pharmaceuticals.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Kiora Stock Analysis
When running Kiora Pharmaceuticals' price analysis, check to measure Kiora Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kiora Pharmaceuticals is operating at the current time. Most of Kiora Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kiora Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kiora Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kiora Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.